AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35409444 — intervention group
Group type: EXPERIMENTAL
Intervention: Literacy group
Number of subjects: 25
Study 35409444 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 25
Study 35409444 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 25
Study 33085560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral rectus plication (n = 27)
Number of subjects: 57
Study 33085560 — intervention group
Group type: COMPARATOR
Intervention: Lateral rectus resection (n = 30)
Number of subjects: 57
Study 33085560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral rectus plication
Number of subjects: 57
Study 33085560 — intervention group
Group type: COMPARATOR
Intervention: Lateral rectus resection
Number of subjects: 57
Study 34822140 — intervention group
Group type: EXPERIMENTAL
Intervention: MiBoFlo Thermoflo®
Number of subjects: 54
Study 34822140 — intervention group
Group type: COMPARATOR
Intervention: LipiFlow®
Number of subjects: 54
Study 33583149 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide and 0.1% tretinoin for 12 weeks (TRT)
Number of subjects: 30
Study 33583149 — intervention group
Group type: COMPARATOR
Intervention: Budesonide for 24 weeks (CTR)
Number of subjects: 30
Study 33060100 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobutrol
Number of subjects: 32
Study 33060100 — intervention group
Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 32
Study 33060100 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobutrol and Gadoterate meglumine
Number of subjects: 32
Study 35426149 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week duration)
Number of subjects: 60
Study 35426149 — intervention group
Group type: COMPARATOR
Intervention: Control group (two 2-hour lectures about mindfulness over 8 weeks)
Number of subjects: 60
Study 33631357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg orally daily for 14 days
Number of subjects: 100
Study 33631357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32363556 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (10,000 IU twice weekly) combined with clomiphene citrate (50 mg twice daily for 5 days)
Number of subjects: 186
Study 32363556 — intervention group
Group type: COMPARATOR
Intervention: Placebo with calcium (1250 mg twice daily) combined with clomiphene citrate (50 mg twice daily for 5 days)
Number of subjects: 186
Study 34190883 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention (six telephone interventions over three months)
Number of subjects: 102
Study 34190883 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional follow-up)
Number of subjects: 102
Study 34190883 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergroup analysis after telephone intervention
Number of subjects: 102
Study 32386421 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin treatment for 18 months
Number of subjects: 84
Study 32386421 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of biologic DMARDs (bDMARDs) at follow‐up
Number of subjects: 84
Study 35836172 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot the Difference Teaching Method (SDTM)
Number of subjects: 0
Study 35836172 — intervention group
Group type: COMPARATOR
Intervention: Traditional Flipped Learning (Control)
Number of subjects: 0
Study 34412908 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily until progression or unacceptable toxicity
Number of subjects: 41
Study 35717038 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanochemical ablation
Number of subjects: 0
Study 35717038 — intervention group
Group type: COMPARATOR
Intervention: Thermal ablation
Number of subjects: 0
Study 34062587 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 0
Study 34062587 — intervention group
Group type: COMPARATOR
Intervention: Betalactam-antibiotics
Number of subjects: 0
Study 34062587 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0
Study 34062587 — intervention group
Group type: COMPARATOR
Intervention: Post-treatment patients
Number of subjects: 0
Study 35897322 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor physical activity program
Number of subjects: 36
Study 35897322 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 34468794 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg twice daily)
Number of subjects: 140
Study 34468794 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin E)
Number of subjects: 140
Study 32690274 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC detection and routine re-examination (CTC group)
Number of subjects: 135
Study 32690274 — intervention group
Group type: COMPARATOR
Intervention: Routine re-examination (Control group)
Number of subjects: 135
Study 33407490 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose walnut (30 g/d)
Number of subjects: 210
Study 33407490 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose walnut (60 g/d)
Number of subjects: 210
Study 33407490 — intervention group
Group type: COMPARATOR
Intervention: Control (non-edible gift)
Number of subjects: 210
Study 33407490 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (low dose, high dose, control)
Number of subjects: 210
Study 32192623 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion therapy along with standard counselling
Number of subjects: 517
Study 32192623 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling
Number of subjects: 517
Study 32192623 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard counseling
Number of subjects: 517
Study 32192623 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 517
Study 34714969 — intervention group
Group type: COMPARATOR
Intervention: Abelacimab (30-150 mg) intravenous single doses
Number of subjects: 0
Study 34714969 — intervention group
Group type: COMPARATOR
Intervention: Abelacimab (120 mg and 180 mg) subcutaneous monthly doses
Number of subjects: 0
Study 34714969 — intervention group
Group type: COMPARATOR
Intervention: Abelacimab (intravenous and subcutaneous)
Number of subjects: 0
Study 34133394 — intervention group
Group type: EXPERIMENTAL
Intervention: CL‐Deb (debridement)
Number of subjects: 190
Study 34133394 — intervention group
Group type: COMPARATOR
Intervention: CL‐noDeb (observation)
Number of subjects: 190
Study 36150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 192
Study 36150583 — intervention group
Group type: COMPARATOR
Intervention: Milrinone
Number of subjects: 192
Study 36150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraventricular arrhythmic events
Number of subjects: 192
Study 36150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular arrhythmic events
Number of subjects: 192
Study 36150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 192
Study 36150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical cardioversion
Number of subjects: 192
Study 34344674 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer STRIPES
Number of subjects: 72
Study 34344674 — intervention group
Group type: COMPARATOR
Intervention: School services as usual
Number of subjects: 72
Study 32538455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition knowledge presentation intervention
Number of subjects: 642
Study 32538455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 642
Study 34806782 — intervention group
Group type: EXPERIMENTAL
Intervention: NBM DBS
Number of subjects: 6
Study 34806782 — intervention group
Group type: EXPERIMENTAL
Intervention: GPi DBS
Number of subjects: 6
Study 34806782 — intervention group
Group type: EXPERIMENTAL
Intervention: NBM stimulation
Number of subjects: 6
Study 34806782 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of tissue activated in the left NBM
Number of subjects: 6
Study 33743343 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 28
Study 33743343 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 36432401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary prescription with nutritional recommendations, nutritional education program based on playful strategies, suggestions of typical and accessible Brazilian foods and intensive monitoring
Number of subjects: 2360
Study 36432401 — intervention group
Group type: COMPARATOR
Intervention: Conventional nutritional counseling
Number of subjects: 2360
Study 36432401 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 2360
Study 36432401 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2360
Study 34481326 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) nasal spray
Number of subjects: 96
Study 34481326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 32561410 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy with CADe
Number of subjects: 40
Study 32561410 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy without CADe
Number of subjects: 40
Study 35482329 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity cycling
Number of subjects: 114
Study 35482329 — intervention group
Group type: EXPERIMENTAL
Intervention: Light intensity cycling
Number of subjects: 114
Study 35482329 — intervention group
Group type: COMPARATOR
Intervention: Both exercise groups
Number of subjects: 114
Study 35482329 — intervention group
Group type: EXPERIMENTAL
Intervention: CRF change
Number of subjects: 114
Study 35482329 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD‐CVR
Number of subjects: 114
Study 34486356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cover crop residue from Calopogonium mucunoides
Number of subjects: 0
Study 34486356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cover crop residue (general)
Number of subjects: 0
Study 34486356 — intervention group
Group type: COMPARATOR
Intervention: Control (no cover crop residue)
Number of subjects: 0
Study 32742637 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent financial incentive (£10 note in addition to a routinely provided £10 voucher)
Number of subjects: 434
Study 32742637 — intervention group
Group type: COMPARATOR
Intervention: No contingent financial incentive (control)
Number of subjects: 434
Study 32742637 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent financial incentive
Number of subjects: 434
Study 35739046 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Management Multidisciplinary Program (MP)
Number of subjects: 96
Study 35739046 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 96
Study 33617961 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC) - 4 cycles of 5 min intermittent leg ischemia and 5 min reperfusion
Number of subjects: 55
Study 33617961 — intervention group
Group type: COMPARATOR
Intervention: SHAM preconditioning
Number of subjects: 55
Study 34101856 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman device
Number of subjects: 97
Study 34101856 — intervention group
Group type: EXPERIMENTAL
Intervention: LAmbre device
Number of subjects: 97
Study 32945627 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (daily dosage not specified) for 6 months
Number of subjects: 0
Study 32945627 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 0
Study 36154873 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed aerobic and strength training once a week for 12 months
Number of subjects: 0
Study 36154873 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 616497132 — intervention group
Group type: EXPERIMENTAL
Intervention: PEM 1%
Number of subjects: 221
Study 616497132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 32710585 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal cream (cream A) applied topically twice-daily
Number of subjects: 35
Study 32710585 — intervention group
Group type: COMPARATOR
Intervention: Control cream (cream B) applied topically twice-daily
Number of subjects: 35
Study 33879077 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 1
Study 33879077 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab (resumed recommended dose after trial of weaning)
Number of subjects: 1
Study 33879077 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab (initial treatment)
Number of subjects: 1
Study 33012286 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib
Number of subjects: 31
Study 35578297 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe inserts
Number of subjects: 36
Study 34763638 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial ablation (BA) with coronary bypass (CB)
Number of subjects: 116
Study 34763638 — intervention group
Group type: COMPARATOR
Intervention: Left atrial ablation (LAA) with coronary bypass (CB)
Number of subjects: 116
Study 33172136 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week CoD sprint training program (INT)
Number of subjects: 16
Study 33172136 — intervention group
Group type: COMPARATOR
Intervention: Regular basketball training (CON)
Number of subjects: 16
Study 35241817 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (BP < 120/80 mmHg)
Number of subjects: 1074
Study 35241817 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control (BP < 140/90 mmHg)
Number of subjects: 1074
Study 33436973 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) use
Number of subjects: 891395
Study 33436973 — intervention group
Group type: COMPARATOR
Intervention: Control (non-ICS users)
Number of subjects: 891395
Study 35433550 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional support program
Number of subjects: 80
Study 34259400 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (tapping at acupoints along meridian + thunder-fire moxibustion)
Number of subjects: 140
Study 34259400 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint-tapping group (tapping along the large intestine meridian)
Number of subjects: 140
Study 34259400 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion group (thunder-fire moxibustion at affected side)
Number of subjects: 140
Study 34259400 — intervention group
Group type: COMPARATOR
Intervention: Routine group (routine treatment and nursing)
Number of subjects: 140
Study 34259400 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 140
Study 35059825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronation-Extension (PE) position
Number of subjects: 50
Study 35059825 — intervention group
Group type: COMPARATOR
Intervention: Neutral position
Number of subjects: 50
Study 33469679 — intervention group
Group type: EXPERIMENTAL
Intervention: OVV-Beclin1
Number of subjects: 0
Study 33469679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of OVV-Beclin1 and R-CHOP
Number of subjects: 0
Study 33705273 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 h group
Number of subjects: 120
Study 33705273 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 h group
Number of subjects: 120
Study 33705273 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 h group
Number of subjects: 120
Study 33705273 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h group
Number of subjects: 120
Study 34109609 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% 5-Fluorouracil (5-FU) cream
Number of subjects: 0
Study 33858561 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO) combined with chemotherapy
Number of subjects: 35
Study 33858561 — intervention group
Group type: COMPARATOR
Intervention: Traditional chemotherapy
Number of subjects: 35
Study 32586362 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary-school-based intervention to reduce suicidal ideation among adolescents
Number of subjects: 0
Study 32586362 — intervention group
Group type: EXPERIMENTAL
Intervention: Community storage facility intervention to reduce access to pesticides
Number of subjects: 0
Study 32586362 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for community health workers in recognition, management, and appropriate referral of people identified with high suicidal risk
Number of subjects: 0
Study 36177741 — intervention group
Group type: EXPERIMENTAL
Intervention: metronidazole gel (0.75%)
Number of subjects: 130
Study 36177741 — intervention group
Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 130
Study 33230561 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron sucrose
Number of subjects: 0
Study 33230561 — intervention group
Group type: COMPARATOR
Intervention: Oral iron
Number of subjects: 0
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based individual physical activity challenge
Number of subjects: 76
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based friend physical activity challenge
Number of subjects: 76
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based team physical activity challenge
Number of subjects: 76
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention incorporating self-monitoring and physical activity challenges
Number of subjects: 76
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: External and identified regulations
Number of subjects: 76
Study 32915158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic and introjected regulations
Number of subjects: 76
Study 34218516 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Biofilm Therapy (GBT) using erythritol powder (AIRFLOW®)
Number of subjects: 50
Study 34218516 — intervention group
Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 50
Study 33706750 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 10% high cleaning silica, 0.5% sodium phytate and 0.5% sodium pyrophosphate
Number of subjects: 86
Study 32767983 — intervention group
Group type: EXPERIMENTAL
Intervention: Data Quality Assessments (DQA) conducted in health facilities from 2016 to 2018
Number of subjects: 444
Study 32767983 — intervention group
Group type: EXPERIMENTAL
Intervention: Data Quality Assessments (DQA) conducted in health facilities
Number of subjects: 444
Study 35197363 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib
Number of subjects: 0
Study 35197363 — intervention group
Group type: EXPERIMENTAL
Intervention: JAK inhibitors
Number of subjects: 0
Study 32918512 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-sec intervention including physician's very brief advice, a leaflet with graphic warnings, and a card with contact information of available cessation services
Number of subjects: 13671
Study 32994251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.145% fluoride gel applied using custom trays after brushing every night while sleeping
Number of subjects: 80
Study 32994251 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instructions as usual
Number of subjects: 80
Study 35803884 — intervention group
Group type: EXPERIMENTAL
Intervention: CFRD
Number of subjects: 117
Study 35803884 — intervention group
Group type: COMPARATOR
Intervention: No CFRD
Number of subjects: 117
Study 33902562 — intervention group
Group type: EXPERIMENTAL
Intervention: pNIV (portable non-invasive ventilation) with inspiratory/expiratory positive airway pressure of 18/8 cmH2O
Number of subjects: 61
Study 33902562 — intervention group
Group type: COMPARATOR
Intervention: No pNIV (control group)
Number of subjects: 61
Study 35156692 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMS‐IMRT
Number of subjects: 40
Study 35156692 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 40
Study 33650454 — intervention group
Group type: EXPERIMENTAL
Intervention: GENIE protocol (n = 382)
Number of subjects: 1404
Study 33650454 — intervention group
Group type: COMPARATOR
Intervention: FORMULA protocol (n = 289)
Number of subjects: 1404
Study 33650454 — intervention group
Group type: EXPERIMENTAL
Intervention: GENIE overall (n = 1404)
Number of subjects: 1404
Study 33650454 — intervention group
Group type: COMPARATOR
Intervention: Euglycemic no-insulin cohort (ENo-I, n = 111)
Number of subjects: 1404
Study 35330828 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg in 10 min) followed by a constant infusion rate (0.5 μg kg−1 h−1) (D2 group)
Number of subjects: 165
Study 35330828 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine at a constant infusion rate (0.5 μg kg−1 h−1) (D1 group)
Number of subjects: 165
Study 35330828 — intervention group
Group type: COMPARATOR
Intervention: Propofol- and remifentanil-based total intravenous anesthesia (T group)
Number of subjects: 165
Study 32860034 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine initiated < Day 3
Number of subjects: 4661
Study 32860034 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine initiated between Days 4 and 7
Number of subjects: 4661
Study 32860034 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine initiated > Day 8
Number of subjects: 4661
Study 32860034 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (early initiation)
Number of subjects: 4661
Study 32860034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4661
Study 36416665 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Oxygen Administration (AOA)
Number of subjects: 18
Study 33331859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg and 2.0 mg, administered monthly or on an as-needed basis over 24 months
Number of subjects: 586
Study 33331859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (as-needed arm)
Number of subjects: 586
Study 33331859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 586
Study 33544277 — intervention group
Group type: EXPERIMENTAL
Intervention: RUSH program (12-week intervention)
Number of subjects: 55
Study 33544277 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 55
Study 33066098 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational physicians’ perspectives on employee participation in health promotion measures for musculoskeletal disorders (MSDs)
Number of subjects: 8